Top U.S. cholesterol-lowering drugs by revenue market share 2013
This statistic shows the top ten HMG-CoA reductase inhibitors based on U.S. revenue market share in 2013. In that year, Livalo was among the leading HMG-CoA reductase inhibitors generating a market share of 1.9 percent based on revenues in the United States. HMG-CoA reductase inhibitors or statins help lower cholesterol levels and is central in cholesterol production within the liver. It is used to prevent heart disease and decrease mortality within those with pre-existing cardiovascular disease.
